Caplin Point Laboratories: Caplin Point Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024

Caplin Point Laboratories Limited reported earnings results for the third quarter and nine months ended December 31, 2024. For the third quarter, the company reported sales was INR 4,929.6 million compared to INR 4,355 million a year ago. Revenue was INR 5,243.2 million compared to INR 4,526.8 million a year ago. Net income was INR 1,389.6 million compared to INR 1,172 million a year ago. Basic earnings per share from continuing operations was INR 18.28 compared to INR 15.44 a year ago. Diluted earnings per share from continuing operations was INR 18.19 compared to INR 15.39 a year ago. For the nine months, sales was INR 14,350.2 million compared to INR 12,408.8 million a year ago. Revenue was INR 15,057.1 million compared to INR 12,905.3 million a year ago. Net income was INR 3,937.4 million compared to INR 3,355 million a year ago. Basic earnings per share from continuing operations was INR 51.82 compared to INR 44.19 a year ago. Diluted earnings per share from continuing operations was INR 51.55 compared to INR 44 a year ago.